Elsevier

Nutrition Research

Volume 29, Issue 7, July 2009, Pages 437-456
Nutrition Research

Green tea and bone metabolism

https://doi.org/10.1016/j.nutres.2009.06.008Get rights and content

Abstract

Osteoporosis is a major health problem in both elderly women and men. Epidemiological evidence has shown an association between tea consumption and the prevention of age-related bone loss in elderly women and men. Ingestion of green tea and green tea bioactive compounds may be beneficial in mitigating bone loss of this population and decreasing their risk of osteoporotic fractures. This review describes the effect of green tea or its bioactive components on bone health, with an emphasis on (i) the prevalence and etiology of osteoporosis; (ii) the role of oxidative stress and antioxidants in osteoporosis; (iii) green tea composition and bioavailability; (iv) the effects of green tea and its active components on osteogenesis, osteoblastogenesis, and osteoclastogenesis from human epidemiological, animal, as well as cell culture studies; (v) possible mechanisms explaining the osteoprotective effects of green tea bioactive compounds; (vi) other bioactive components in tea that benefit bone health; and (vii) a summary and future direction of green tea and bone health research and the translational aspects. In general, tea and its bioactive components might decrease the risk of fracture by improving bone mineral density and supporting osteoblastic activities while suppressing osteoclastic activities.

Introduction

Osteoporosis is a degenerative bone disease characterized by low bone mass and microarchitectural deterioration of bone tissue that leads to bone fragility and an increased susceptibility to fractures, especially in the hip, spine, and wrist [1]. Osteoporosis research has also reported some gender disparities. Women are 4 times more likely than men to develop osteoporosis because of a decrease in their estrogen levels after menopause in conjunction with generally lighter and thinner bones [2]. The rapid decrease in bone mineral density (BMD) that occurs in the first 3 to 5 years immediately after menopause and the slower decrease that continues throughout the remainder of a woman's life markedly increase the risk of hip or vertebral fracture, which is a major cause of morbidity and mortality in older women [2], [3]. More than half of postmenopausal women will experience a bone fracture as the result of osteoporosis [4]. Similarly, 1 of 4 osteoporosis patients is male, and 30% of hip fractures occur in men [5]. The pathogenesis of osteoporosis in men is still poorly understood; it has been reported that approximately one third of osteoporotic men have an idiopathic disease [6].

Hip fracture is the most severe consequence of osteoporosis, leading to reduced activities of daily living, lowered quality of life, and increased mortality of patients [7], [8]. As the population ages worldwide, osteoporosis has become a serious health threat in many countries [7], [8]. It is estimated that almost 44 million American women and men 50 years and older have osteoporosis and low bone mass. By the year 2010, it is estimated that more than 52 million women and men in this same age category will be affected, and if current trends continue, the number will climb to more than 61 million by 2020 [9]. The economic costs due to hip fractures have increased tremendously in the past decade and are predicted to grow [10], [11], [12].

To predict the risk of fractures, clinical application of bone densitometry, such as dual-energy x-ray absorptiometry, is generally used to measure BMD at the spine, hip, and femoral neck. This method is also used to monitor the natural progression of diseases that affect BMD, or the therapeutic response to osteoporosis-specific treatments 1 to 2 years after beginning treatment [13], [14], [15], [16]. Low areal BMD is the most important risk factor for hip fractures [17].

Recent research has suggested that BMD is positively associated with tea consumption, which may optimize bone health. The bioactive components in tea may benefit bone health in terms of maintaining higher BMD [18], [19], [20], [21], [22], [23] and reducing the risk of fracture [24], [25]. Specifically, green tea seemed to benefit bone health more than other kinds of tea (eg, black and oolong), which may be due to decreased oxidative stress [26], [27], increased activity of antioxidant enzymes [26], and decreased expression of proinflammatory mediators [26], [27]. In this review, we discuss the beneficial osteoprotective effects of green tea and its bioactive components. In addition, the possible mechanisms of osteoprotection of green tea along with its bioactive components are discussed.

Section snippets

Role of oxidative stress and antioxidants in osteoporosis

Both osteoblastic and osteoclastic cells regulate bone metabolism, and both cell types are involved in the development of osteoporosis [28]. Osteoblasts are bone-forming cells located near the surface of the bone that produces cytokines. Cytokines, including macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor κB (NF-κB) ligand (RANKL), are both essential for osteoclast differentiation, function, and survival [29], [30]. Osteoclasts are bone-resorbing

Green tea composition and bioavailability

Drinking green tea and/or ingesting green tea bioactive compounds may mitigate bone loss in elderly women and men, thereby decreasing their risk of osteoporotic fractures. Tea, the dried leaves of the Camellia sinensis species of the Theaceae family, is a popular beverage with an annual production of 3 billion kilograms. Of the tea produced worldwide, 78% is black tea, which is usually consumed in Western countries; 20% is green tea, which is commonly consumed in Asian countries; and 2% is

Beneficial effects of tea on bone health

The health benefits of tea consumption in preventing cancers and cardiovascular diseases have been intensively investigated [57]. However, limited information is available about the protective effect of consumption of green tea or its bioactive components on bone health. In this section, we summarize the impact of tea or green tea and its bioactive components on bone health, including human, animal, and cellular studies [58].

Possible mechanisms of green tea on osteoprotection

There are 5 main possible mechanisms through which green tea protects bone health: (1) by mitigating bone loss through antioxidative stress action, (2) by mitigating bone loss through anti-inflammatory action, (3) by enhancing osteoblastogenesis, (4) by suppressing osteoclastogenesis, and (5) probably through osteoimmunological action.

Other bioactive components in tea that benefit bone health

Besides the catechins, tea is also an important source of flavonoids, caffeine, and dietary fluoride [173]. Fluoride intake can alleviate osteoporotic progression [174]. Fluoride concentration in tea brewed in fluoride-free water ranges from negligible to 4 parts per million, depending on the type and amount of tea used. Three or more cups of tea daily would be expected to increase fluoride intake by up to 4 mg daily. Therefore, the relatively high-fluoride content of the tea leaves may enhance

Summary and future research

Osteoporosis is the result of an imbalance in the ratio with more resorption than formation. Enhancing the activity of osteoblasts, plus reducing that of the osteoclasts, may help restore the balance in bone metabolism and limit bone loss in the development of osteoporosis. There is mounting evidence that green tea contains many bioactive ingredients that support some protection against osteoporosis. This is supported by data from in vitro, ex vivo, and in vivo animal studies and human

Acknowledgment

The preparation of this review was supported by National Institutes of Health/National Center for Complementary and Alternative Medicine grant R21AT003735, the Laura W. Bush Institute for Women's Health (C.L.S.), and National Institutes of Health/NCI grant CA90997 (J.S.W.). The authors thank Ryan K. Boettger, Angela Eaton, and Cynthia R. Davidson for their editorial contribution.

References (184)

  • DreherI. et al.

    Selenoproteins are expressed in fetal human osteoblast-like cells

    Biochem Biophys Res Commun

    (1998)
  • YangS. et al.

    A new superoxide-generating oxidase in murine osteoclasts

    J Biol Chem

    (2001)
  • SontakkeA.N. et al.

    A duality in the roles of reactive oxygen species with respect to bone metabolism

    Clin Chim Acta

    (2002)
  • PolidoriM.C. et al.

    Profiles of antioxidants in human plasma

    Free Radic Biol Med

    (2001)
  • YangC.S. et al.

    Effects of tea consumption on nutrition and health

    J Nutr

    (2000)
  • LiaoS. et al.

    Green tea: biochemical and biological basis for health benefits

    Vitam Horm

    (2001)
  • LambertJ.D. et al.

    Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice

    J Nutr

    (2003)
  • VestergaardP. et al.

    Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women

    Maturitas

    (2001)
  • SaitogluM. et al.

    Osteoporosis risk factors and association with somatotypes in males

    Arch Med Res

    (2007)
  • WangJ.S. et al.

    Validation of green tea polyphenol biomarkers in a phase II human intervention trial

    Food Chem Toxicol

    (2008)
  • ShenC.L. et al.

    Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats

    Bone

    (2009)
  • GregerJ.L. et al.

    Iron, copper and zinc metabolism of rats fed various levels and types of tea

    J Nutr

    (1988)
  • AlmeidaM. et al.

    Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids

    J Biol Chem

    (2007)
  • PettitA.R. et al.

    TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

    Am J Pathol

    (2001)
  • SammanS. et al.

    Green tea or rosemary extract added to foods reduces nonheme-iron absorption

    Am J Clin Nutr

    (2001)
  • ValiB. et al.

    Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells

    J Nutr Biochem

    (2007)
  • HayashiK. et al.

    (−)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts

    Life Sci

    (2008)
  • YamauchiJ. et al.

    (−)-Epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts

    Prostaglandins Leukot Essent Fatty Acids

    (2007)
  • TokudaH. et al.

    Incadronate amplifies prostaglandin F2α-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity

    J Biol Chem

    (2003)
  • National Institutes of Health

    Osteoporosis prevention, diagnosis, and therapy

    NIH Consensus Statement Online

    (2000)
  • LookerA.C. et al.

    Prevalence of low femoral bone density in older U.S. women from NHANES III

    J Bone Miner Res

    (1995)
  • National Osteoporosis Foundation
  • Osteoporosis in Men. http://www.nof.org/men/index.htm (searched on April 9,...
  • U.S.D.H.H.S

    The frequency of bone disease

  • BoonenS. et al.

    Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I

    Curr Med Res Opin

    (2008)
  • America's bone health: the state of osteoporosis and low bone mass. Available at:...
  • KonnopkaA. et al.

    The health and economic consequences of osteopeni- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050

    Osteoporosis Int

    (2008)
  • BurgeR. et al.

    Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025

    J Bone Miner Res

    (2007)
  • RayN.F. et al.

    Medical expenditure for the treatment of osteoporotic fractures in the United States in 1995 report from the National Osteoporosis Foundation

    J Bone Miner Res

    (1997)
  • MillerL.J. et al.

    Relative contributions of bone density, bone turnover, and clinical risk factors to long-tern fracture prediction

    J Bone Miner Res

    (2003)
  • HuiS.L. et al.

    Age and bone mass predictors of fracture in a prospective study

    J Clin Invest

    (1988)
  • MarshallD. et al.

    Meta-analysis of how well measurements of bone mineral density predict the occurrence of osteoporotic fractures

    BMJ

    (1996)
  • BauerD.C. et al.

    Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women

    Arch Int Med

    (1997)
  • CummingsS.R. et al.

    Appendicular bone density and age predict hip fracture in women

    JAMA

    (1990)
  • Hamdi KaraI. et al.

    Habitual tea drinking and bone mineral density in postmenopausal Turkish women: Investigation of Prevalence of Postmenopausal Osteoporosis in Turkey (IPPOT Study)

    Int J Vitam Nutr Res

    (2007)
  • WuC.H. et al.

    Epidemiological evidence of increased bone mineral density in habitual tea drinkers

    Arch Intern Med

    (2002)
  • HooverP.A. et al.

    Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity

    Can J Physiol Pharmacol

    (1996)
  • JohnellO. et al.

    Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study

    J Bone Miner Res

    (1995)
  • KanisJ. et al.

    Risk factors for hip fracture in men from southern Europe: the MEDOS Study. Mediterranean Osteoporosis Study

    Osteoporos Int

    (1999)
  • ShenC.L. et al.

    Protective effect of green tea polyphenols on bone loss in middle-aged female rats

    Osteoporosis Int

    (2008)
  • Cited by (150)

    • Epigallocatechin gallate regulates inflammatory responses and new bone formation through Wnt/β-Catenin/COX-2 pathway in spondyloarthritis

      2021, International Immunopharmacology
      Citation Excerpt :

      Moreover, the bone formation, absorption and metabolism have been proved to be regulated by EGCG [11]. Further, EGCG could reduce the damage of zoledronic acid on osteoblasts, enhance the formation of mineralized bone nodules, inhibit inflammatory bone absorption, modulate osteoclast formation, differentiation and maturation [12–16]. Therefore, EGCG has the function of regulating inflammation and bone metabolism, but whether EGCG can improve SpA remains unclear.

    View all citing articles on Scopus
    View full text